A preliminary investigation on the acute pharmacodynamic effects of hypericum on cognitive and psychomotor performance

Behavioural Pharmacology

Volumn 12, Issue 8, 2001, Pages 635-640

  Timoshanko, A ^a   Stough, C ^a   Vitetta, L ^a   Nathan, P J ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Amitriptyline; Antidepressants; Behavioral effects; Cognitive and psychomotor function; Human; Hypericum (St John's wort)

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BLACKMORE HYPERIFORTE; HYPERICUM PERFORATUM EXTRACT; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERICUM PERFORATUM; INFORMATION PROCESSING; MALE; MOOD; NAUSEA; NORMAL HUMAN; PERFORMANCE; PHARMACODYNAMICS; PSYCHOLOGIC TEST; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESPONSE TIME; SEDATION; SENSORIMOTOR FUNCTION; SYMBOLISM; VOMITING;

EID: 0035666841     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200112000-00008     Document Type: Article

References (51)

1. Measurement of feelings using visual analogue rating scales
2. Effects of antidepressants on cognitive functions: A review
3. Bioavailability of hyperforin from hypericum extracts in rats and human volunteers
4. The place for the tricyclic antidepressants in the treatment of depression
5. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: A double-blind randomized pilot study
6. Hypericin and pseudohypericin: Pharmacokinetics and effects on photosensitivity in humans
7. Drowsiness, impaired performances and tricyclic antidepressants
8. Hyperforin as a possible antidepressant component of hypericum extracts
9. Antidepressant activity of hypericum perforatum and hyperforin: The neglected possibility
10. Antidepressants and human memory: An investigation of four drugs with different sedative and anticholinergic properties
11. The scientific, quasi-scientific and popular literature on the use of St. John's Wort in the treatment of depression
12. Effects of antidepressants on human performance: A review
13. Second thoughts about the safety of St Johns Wort
14. Effects of fluvoxamine and dothiepin on psychomotor abilities in healthy volunteers
15. St John's Wort for depression
16. Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: A multicentre double-blind study
17. A review of the psychomotor effects of paroxetine
18. Measuring the effect of psychoactive drugs on higher brain function
19. Three antidepressants (amitriptyline, dothiepin, fluoxetine) with and without alcohol, compared with placebo on tests of psychomotor ability related to car driving
20. A pharmacological profile of fluoxetine and other antidepressants on aspects of skilled performance and car handling ability
21. The behavioural effects of antidepressants: Effects on cognition and sexual dysfunction
22. The effects of antidepressants on psychomotor function with particular reference to reboxetine
23. Psychopharmacological effects of sertraline in normal, healthy volunteers
24. The effects of paroxetine and other antidepressants in combination with alcohol in psychomotor activity related to car driving
25. Behavioural toxicity of antidepressants with particular reference to moclobemide
26. Pharmacodynamics of milnacipran in young and elderly volunteers
27. Critical flicker fusion test for sedative effect of antidepressants
28. Pharmacological characterization of selective serotonin re-uptake inhibitors (SSRIs)
29. Human cognitive function following binedaline (50mg and 100mg) and imipramine (75 mg): Results with a new battery of tests
30. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin
31. The comparative psychopharmacology of 5HT re-uptake inhibitors
32. The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects
33. St John's Wort for depression - An overview and meta-analysis of randomised clinical trials
34. Effects of hypericum extrct IL160 in biochemical models of antidepressant activity
35. Hypericum perforatum (St. John's Wort): A non-selective reuptake inhibitor (NSRI)? A review of the recent advances in its pharmacology
36. Serotonin, noradrenaline and cognitive function: A preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor
37. Venlafaxine's effects on healthy volunteers' driving, psychomotor and vigilance performance during 15-day fixed and incremental dosing regimes
38. Pharmacokinetics of milnacipran in comparison with other antidepressants
39. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers
40. Clinical pharmacology of befloxatone: A brief review
41. Equivalence of St. John's Wort extract (Ze 117) and fluoxetine: A randomised, controlled study in mild to moderate depression
42. A comparison of five commonly prescribed antidepressants with particular reference to their behavioural toxicity
43. The reliability, validity and pharma-cosensitivity of four psychomotor tests
44. Pharmacokinetics of hypericin after oral intake of the hypericum extract LI 160 in healthy volunteers
45. Non-MAOI antidepressant drugs and cognitive functions - A review
46. LI 160, an extract of St John's Wort, versus amitriptyline in mildly to moderately depressed out patients - A controlled 6-week clinical trial
47. Comparison of St. John's Wort and imipramine for treating depression: Randomised controlled trial
48. Inhibition of synaptosomal uptake of 3H-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: The role of amiloride sensitive sodium conductive pathways